Opioid Abuse and the OMS Patient: Future of Prescribing

Thursday, October 10, 2013
7:00 AM-9:00 AM

Valencia Ballroom W415B-C (Orange County Convention Center)

This is a non-ticketed session.
  • White_Misuse_Abuse_Controlled_Substances10-9.pdf (239.9 kB)
  • Moderator:

    Gary H. Dwight DDS, MS
    East Lansing, MI, USA


    R. Dean White DDS, MS
    Granbury, TX, USA

    CDE/CME Offered: CDE/CME

    *Please note that due to the recent government shutdown, Mr. Kerlikowske is unable to present at this session. Dr. White has adapted his presentation to summarize many of Mr. Kerlikowske’s topics. We look forward to an informative discussion.*

    Prevent, Expand, Reform and Support. These four words represent the cornerstone of the White House’s plan to reform our nation’s drug policy, which includes prescription drugs. According to the White House Office of National Drug Control Policy, the reform drug policy highlights are: 1. Prevent drug use before it ever begins through education; 2. Expand access to treatment for Americans struggling with addiction; 3. Reform our criminal justice system to break the cycle of drug use, crime, and incarceration; and 4. Support Americans in recovery and lift the stigma associated with substance use disorders. The hope is that millions of people in the United States will soon become eligible (within the next year) to receive treatment for substance abuse under the Affordable Care Act. This, coupled with reforms in the criminal justice system to increase the number of drug courts and probation programs, should assist in reducing incarceration rates, as the country’s drug policies transition to being “smart on crime” as opposed to “tough on crime.”

    Attend this session to learn from experts in the field, including the nation’s drug czar, and discuss the impact this could have on the oral and maxillofacial surgery office and your patients.

    Learning Objectives
    1. Describe and discuss aspects of the Affordable Care Act that will impact the OMS patient who is abusing opioids;
    2. Implement educational tools for patients for the prevention of opioid abuse; and
    3. Provide opportunities for and support of patients seeking assistance for opioid abuse.

    » Back to: Symposia